Clinical Trial Update: DDAVP for Pituitary Adenoma [NA]

View source ↗

Summary

A clinical trial is evaluating desmopressin (DDAVP) for Cushing's disease and pituitary adenoma, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Disease
• Pituitary Adenoma

Drugs mentioned

• DDAVP (desmopressin acetate)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Cushing's Disease, Pituitary Adenoma | NA | Status: RECRUITING